ACRIVON THERAPEUTICS INC's ticker is and the CUSIP is 004890109. A total of 44 filers reported holding ACRIVON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sands Capital Ventures, LLC | 1,652,605 | $15,798,904 | 4.67% |
| Perceptive Advisors | 3,007,858 | $28,755,122 | 0.96% |
| RA Capital Management | 4,810,508 | $45,988,456 | 0.90% |
| NEA Management Company, LLC | 430,252 | $4,113,209 | 0.32% |
| DAFNA Capital Management LLC | 76,852 | $734,705 | 0.23% |
| AAF Wealth Management, LLC | 10,678 | $102,082 | 0.07% |
| UBS OCONNOR LLC | 105,000 | $1,003,800 | 0.02% |
| MARSHALL WACE, LLP | 597,469 | $5,711,804 | 0.01% |
| FEDERATED HERMES, INC. | 226,375 | $2,164,145 | 0.01% |
| EXCHANGE TRADED CONCEPTS, LLC | 9,919 | $94,826 | 0.00% |
| Citadel Advisors | 1,650,457 | $15,778,369 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 888,130 | $8,490,523 | 0.00% |
| NORTHERN TRUST CORP | 72,722 | $695,223 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Legal & General Group Plc | 839 | $8,021 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 189,559 | $1,812,437 | 0.00% |
| STATE STREET CORP | 133,276 | $1,274,119 | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 2,297 | $22 | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 12 | $115 | 0.00% |
| STRS OHIO | 800 | $7 | 0.00% |
This page lists ACRIVON THERAPEUTICS INC's shareholders in Q3 2023. To view ACRIVON THERAPEUTICS INC's shareholder history, click here.